Gevo, Inc. (NASDAQ:GEVO) Files An 8-K Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition.

On August 3, 2017, Gevo, Inc. (the “Company”) issued a press release announcing the Company’s financial results for the second quarter ended June 30, 2017. A copy of this press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

Item 2.02. Financial Statements and Exhibits.

(d) Exhibits.

The information contained herein and in the accompanying exhibit shall not be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing, unless expressly incorporated by specific reference to such filing. The information in this report, including the exhibit hereto, shall not be deemed to be “filed” for purposes of Section18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section.

Gevo, Inc. Exhibit
EX-99.1 2 gevo-ex991_6.htm EX-99.1 gevo-ex991_6.htm   Exhibit 99.1 Gevo Reports 2nd Quarter 2017 Financial Results Completion of Bond Exchange with Whitebox Restructures Gevo’s Balance Sheet   – Gevo to Host Conference Call Today at 4:30 p.m. EDT/2:30 MDT –   • Reports net loss per share of ($0.66) for the quarter     • Reports non-GAAP Adjusted Net Loss Per Share1 of ($0.44) for the quarter   • Ended the quarter with cash and cash equivalents of $16.3 million   • Reports revenue of $7.5 million for the quarter   • Reports loss from operations of $6.2 million for the quarter   • Reports non-GAAP Cash EBITDA Loss2 of $4.4 million for the quarter ENGLEWOOD,…
To view the full exhibit click here

About Gevo, Inc. (NASDAQ:GEVO)

Gevo, Inc. (Gevo) is a renewable chemicals and next generation biofuels company. The Company has developed a technology that uses a combination of synthetic biology, metabolic engineering, chemistry and chemical engineering to focus primarily on the production of isobutanol, as well as related products from renewable feedstock. It has two operating segments: the Gevo, Inc. segment and the Gevo Development/Agri-Energy segment. Its Gevo, Inc. segment is responsible for research and development activities related to the future production of isobutanol, including the development of its biocatalysts, the production and sale of biojet fuel, its Retrofit process and the next generation of chemicals and biofuels that will be based on its isobutanol technology. Its Gevo Development/Agri-Energy segment is responsible for the operation of its Agri-Energy Facility and the production of ethanol, isobutanol and related products.